Gilead Sciences Operating Expenses 2011-2026 | GILD

Annual Operating Expenses Gilead Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	13.5 B	9.07 B	7.61 B	8.5 B	6.44 B	5.84 B	3.82 B	3.22 B	2.47 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.5 B	2.47 B	6.72 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	292 M	$ 3.55	-0.28 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	79.7 M	$ 3.26	4.15 %	$ 229 M	Schweiz
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Aptorum Group Limited APM	20.7 M	$ 0.79	0.05 %	$ 4.31 M	China
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
ADC Therapeutics SA ADCT	334 M	$ 4.14	-1.9 %	$ 105 M	Schweiz
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Arcturus Therapeutics Holdings ARCT	158 M	$ 6.55	-1.16 %	$ 179 M	Israel
argenx SE ARGX	2.27 B	$ 711.17	1.12 %	$ 25 B	Niderland
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.43	-4.99 %	$ 8.25 B	Australia
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Ascendis Pharma A/S ASND	338 M	$ 230.22	-0.35 %	$ 5 B	Danmark
BioCardia BCDA	15.7 M	$ 1.3	1.97 %	$ 27.5 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Atea Pharmaceuticals AVIR	181 M	$ 6.12	1.16 %	$ 499 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 3.43	-4.19 %	$ 7.46 B	Israel
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Catalyst Biosciences CBIO	105 M	$ 11.3	-2.46 %	$ 1.01 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Anika Therapeutics ANIK	51.6 M	$ 14.59	1.6 %	$ 214 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
CNS Pharmaceuticals CNSP	14.9 M	$ 2.4	-2.04 %	$ 917 K	USA
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	53.7 M	$ 2.63	-0.57 %	$ 16.5 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.52	0.33 %	$ 388 M	Britain
BioNTech SE BNTX	512 M	$ 94.73	4.62 %	$ 27.2 B	Germany
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA